J. David Enloe Jr - Jan 18, 2022 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Executive Officer, Director
Signature
By: Ryan D. Lake, attorney- in-fact
Stock symbol
SCTL
Transactions as of
Jan 18, 2022
Transactions value $
$1,011
Form type
4
Date filed
1/19/2022, 03:30 PM
Previous filing
Dec 17, 2021
Next filing
Jan 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Purchase $1.01K +602 +0.39% $1.68 155K Jan 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.